Nebraska Administrative Code
Topic - HEALTH AND HUMAN SERVICES SYSTEM
Title 173 - CONTROL OF COMMUNICABLE DISEASE
Chapter 1 - REPORTING AND CONTROL OF COMMUNICABLE DISEASES
Section 173-1-004 - REPORTABLE DISEASES, POISONINGS, AND ORGANISMS: LISTS AND FREQUENCY OF REPORTS

Universal Citation: 173 NE Admin Rules and Regs ch 1 ยง 004

Current through September 17, 2024

The following diseases, poisonings, and organisms are declared to be communicable or dangerous or both to the public Incidents of diseases, poisonings, and organisms must be reported as described in 173 NAC 1-004.01 through 1-004.03, 1-005, and 1-006.

004.01 Immediate Reports

1-004.01A The following diseases, poisonings, and organisms must be reported immediately:

Anthrax (Bacillus anthracis *^

Botulism (Clostridium botulinum *^

Brucellosis (Brucella abortus ^, B. melitensis ^, and B. suis ^*)

Carbapenamase-Resistant Enterobacteriaceae (suspected or confirmed) **^ (not to include Proteus or Providencia species or Morganella morganii)

Cholera (Vibrio cholerae ^

Coccidiodomycosis (Coccidioides immitis/posodasiI )

Diphtheria (Corynebacterium diphtheriae) [DAGGER]

Eastern equine encephalitis (EEE virus *^

Food poisoning, outbreak-associated

Glanders [Burkholderia (Pseudomonas) mallei *^

Haemophilus influenzae infection (invasive disease only ) ^

Hantavirus pulmonary syndrome (Sin Nombre virus)

Hemolytic uremic syndrome (post-diarrheal illness)

Hepatitis A (IgM antibody-positive or clinically diagnosed during an outbreak)

Hepatitis B infection (positive surface antigen tests, e antigen tests, and all IgM core antibody tests, both positive and negative)

Hepatitis E

Influenza due to novel or pandemic strains (includes highly pathogenic avian influenza virus *^

Measles (Rubeola)

Melioidosis [Burkholderia (Pseudomonas) pseudomallei ] *

Meningitis (Haemophilus influenza [DELTA] or Neisseria meningitidis ) ^

Meningococcal disease, invasive (Neisseria meningitidis )^

Monkeypox virus infection *

Middle East Respiratory Syndrome - suspected or confirmed cases ^

Pertussis [whooping cough] (Bordetella pertussis ^

Plague (Yersinia pestis ) *^

Poliomyelitis, paralytic

Q fever (Coxiella burnetii ) ^*

Rabies (human and animal cases and suspects)

Ricin poisoning *

Rubella and congenital rubella syndrome

Severe Acute Respiratory Syndrome [SARS] (SARS-associated coronavirus)

Smallpox *

Staphylococcal enterotoxin B intoxication *

Staphylococcus aureus, vancomycin-intermediate/resistant as defined by the CDC

Tick-borne encephalitis, virus complexes (Central European Tick-borne encephalitis virus, Far Eastern Tick-borne encephalitis virus, Kyasanur Forest disease virus, Omsk Hemorrhagic Fever virus, Russian Spring and Summer encephalitis virus )

Tularemia (Francisella tularensis *^

Typhus Fever, louse-borne (Rickettsia prowazekii )*^ and flea-borne / endemic murine (Rickettsia typhi)

Venezuelan equine encephalitis*

Viral hemorrhagic fever (including but not limited to Ebola virus, Marburg virus, Congo Crimean Fever) - suspected or confirmed cases *

Yellow Fever

* Potential agents of bioterrorism (designated as select agents by CDC)

^ Laboratories must submit the isolate and/or specimen to the Nebraska Public Health Laboratory as specified in 173 NAC 1-007.03

** Resistance to imipenem, doripenem, ertapenem or meropenem as defined by the CDC.

1-004.01B Clusters, Outbreaks, or Unusual Events, Including Possible Bioterroristic Attacks*: Clusters, outbreaks, or epidemics of any health problem, infectious or other, both in the community and in healthcare settings, including food poisoning, healthcare-associated outbreaks or clusters, influenza, or possible bioterroristic attack; increased disease incidence beyond expectations; unexplained deaths possibly due to unidentified infectious causes; and any unusual disease or manifestations of illness must be reported immediately.

004.02 Reports Within Seven Days

The following diseases, poisonings, and organisms must be reported within seven days of detection or diagnosis:

Acinetobacter spp.,

Acquired Immunodeficiency Syndrome (AIDS), as described in 173 NAC 1-005.01C2

Adenovirus (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Aeromonas (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Amebae-associated infection (Acanthamoeba spp., Entamoeba histolytica, and Naegleria fowleri )

Arboviral infections (including, but not limited to, West Nile virus, St. Louis encephalitis virus, Western Equine Encephalitis virus, Chikunguyna, Rift Valley fever, and Dengue virus) ^

Astrovirus (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Babesiosis (Babesia species)

Campylobacteriosis (Campylobacter ^ sp p.) ^

Carbon monoxide poisoning (use breakpoint for non-smokers)

Chancroid (Haemophilus ducreyi)

Citrobacter spp.

Chlamydia pneumoniae (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Chlamydia trachomatis infections (nonspecific urethritis, cervicitis, salpingitis, neonatal conjunctivitis, pneumonia)

Clostridium difficile (antibiotic-associated colitis and pseudomembranous colitis)

Coronavirus (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Creutzfeldt-Jakob Disease (subacute spongiform encephalopathy [ 14-3-3and Tau protein from CSF or any laboratory analysis of brain tissue suggestive of CJD])

Cryptosporidiosis (Cryptosporidium parvum)

Cyclosporiasis (Cyclospora cayetanensis)

Ehrlichiosis, human monocytic (Ehrlichia chaffeenis)

Ehrlichiosis, human granulocytic (Ehrlichia phagocytophila)

Encephalitis (caused by viral agents)

Entamoeba histolytica

Enterobacter spp.

Enterococcus spp.

Enterovirus (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Escherichia coli gastroenteritis ( to include E. coli O157-H7 ^ and other Shigatoxin-positive E. coli from gastrointestinal infection, Enteroaggregative E. Coli, Enteropathogenic E. coli, Enterotoxigenic E. coli, Shigella/Enteroinvasive E.coli) ^

Escherichia coli

Giardiasis (Giardia lamblia)

Gonorrhea (Neisseria gonorrhoeae)

Hansen's Disease (Leprosy [Mycobacterium leprae])

Hepatitis C infection (all positive screening tests [e.g. EIA , CIA, ELISA, etc.] to include signal-to-cutoff ratio [S:CO] are reportable; all confirmatory tests [e.g. RIBA and PCR for qualitative, quantitative, and genotype testing] are reportable regardless of result [i.e., both positive and negative tests])

Hepatitis D

Herpes simplex, primary genital infection

Histoplasmosis (Histoplasma capsulatum)

Human immunodeficiency virus infection, as described in 173 NAC 1-005.01C2, Type 1 and suspected cases of HIV Type 2

Human Metapneumovirus (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Human Rhinovirus (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Influenza deaths, pediatric (< 20 years of age)

Influenza, all tests positive and negative (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Influenza, rapid tests summary report only (laboratories only)

Kawasaki disease (mucocutaneous lymph node syndrome)

Klebsiella spp.,

Lead poisoning (all analytical values for blood lead analysis must be reported)

Legionellosis (Legionella species)

Leptospirosis (Leptospira interrogans)

Listeriosis (Listeria monocytogenes ) ^

Lyme disease (Borrelia burgdorferi)

Lymphocytic choriomeningitis virus infection

Lymphogranuloma venereum (LGV [Chlamydia trachomatis])

Malaria (Plasmodium species)

Meningitis, including viral, bacterial, and fungal (all such cases must be reported within seven days except those caused by Haemophilus influenzae and Neisseria meningitidis, which must be reported immediately)

Methemoglobinemia / nitrate poisoning (methemoglobin greater than 5% of total hemoglobin)

Mumps

Mycobacteria spp. (including M. tuberculosis complex organisms ^ [for genotyping] and all "atypical" species, to include culture, nucleic acid tests, or positive histological evidence indicative of tuberculosis infection or disease) ^

Mycoplasma pneumoniae (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Necrotizing fasciitis

Norovirus infection (laboratories only)

Parainfluenza (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Plesiomonas shigelloides (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

Poisoning or illness due to exposure to agricultural chemicals (herbicides, pesticides, and fertilizers), industrial chemicals, heavy metals, or radiologic exposures

Psittacosis ( Chlamydia psiittaci)

Pseudomonas aeruginosa

Respiratory syncytial virus infection , all tests positive and negative (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1- 005.02C

Retrovirus infections (other than HIV)

Rheumatic fever, acute (cases meeting the Jones criteria only)

Rocky Mountain Spotted Fever (Rickettsia rickettsii) ^

Rotavirus (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

, Salmonella spp., including typhoid fever (Salmonella serogroup ) ^

Sapovirus

_____Shiga toxin-positive gastroenteritis (enterhemorrhagic E- .coli and other shiga toxin-producing bacteria ) ^

Shigella spp. (Shigella species ) ^

Staphylococcus aureus

Streptococcal disease (all invasive disease caused by Groups A and B streptococci)

Streptococcus pneumonia

_____ Syphilis (Treponema pallidum) RPR reactive and any FTA or other confirmatory test result whether positive or negative; if an EIA is performed first then the follow-up RPR results either positive or negative must be reported.

Syphilis, congenital

Tetanus (Clostridium tetani)

Toxic shock syndrome

Toxoplasmosis, acute (Toxoplasma gondii)

Transmissible spongiform encephalopathies

Trichinosis (Trichinella spiralis)

Tuberculosis (see Mycobacteria)

Varicella zoster primary infections (chicken pox)

Varicella zoster death (all ages)

_____ Vibrio spp. (applies only to laboratories performing electronic lab reporting as specified in 173 NAC 1-005.02C)

_____ Yersiniosis (Yersinia species not Y. pestis)

^ Laboratories must submit the isolate and/or specimen to the Nebraska Public Health Laboratory as specified in 173 NAC 1-007.03

004.03 Reporting of Antimicrobial Susceptibility

All laboratories reporting via automated electronic laboratory reporting (ELR) must report all antimicrobial susceptibility results, including the minimal inhibitory concentration, if performed for bacterial, viral, and fungal isolates listed in 173 NAC 1-004.01 and 1-004.02.

004.04 New or Emerging Diseases and Other Syndromes and Exposures; Reporting and Submissions

1-004.04A Criteria: The Director of the Division of Public Health or the Chief Medical Officer may require reporting, or a change in method or frequency of reporting, of newly recognized or emerging diseases, syndromes suspected to be of infectious origin, or exposures of large numbers or specific groups of persons to known or suspected public health hazards if:
1. The disease, syndrome, or exposure can cause or is suspected to cause serious morbidity or mortality; and

2. Reporting of the disease, syndrome, or exposure is necessary to monitor, prevent, or control the disease, syndrome, or exposure and to protect public health.

1-004.04B Surveillance Mechanism: The Director of the Division of Public Health or the Chief Medical Officer may describe a specific mechanism for surveillance of the disease, syndrome, or exposure including persons and entities required to report, a time frame for reporting, and protocols for the submission of clinical specimens collected from cases, suspected cases, or exposed persons to referral laboratories designated by the DHHS Division of Public Health.

004.05 Sexually Transmitted Diseases

For the purpose of implementing Neb. Rev. Stat. § 71-502.01, sexually transmitted diseases include, but are not limited to, the following diseases:

1. Bacterial vaginosis;

2. Candidiasis;

3. Chancroid;

4. Chlamydia trachomatis infection;

5. Genital herpes infection;

6. Gonorrhea;

7. Granuloma inguinale;

8. Hepatitis B infection;

9. Human immunodeficiency virus (HIV) infection;

10. Human papilloma virus (HPV) infection;

11. Lymphogranuloma venereum;

12. Syphilis; and

13. Trichomoniasis.

004.06 Healthcare Associated Infections

Healthcare Associated Infections: HAIs reported by healthcare facilities to CDC's NHSN are reportable. If a healthcare facility provides access to NSHN HAI data to the department and its local public health department and HAIs are reported to NHSN on a quarterly basis aligning with the CSM Reporting Schedule, the physician is not required to make the HAI report. Physicians remain obligated to report HAIs when access to NHSN data is not provided to the department. In the event of an outbreak, the department has the authority to require HAI data reports from facilities not currently reporting NHSN.

Disclaimer: These regulations may not be the most recent version. Nebraska may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.